In vivo high-frequency, contrast-enhanced ultrasonography of uveal melanoma in mice: Imaging features and histopathologic correlations

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2662-2668

  Zhang, Qing ^a,b   Yang, Hua ^a   Kang, Shin J ^a   Wang, Yanggan ^a   Wang, Geoffrey D ^c   Coulthard, Tonya ^d   Grossniklaus, Hans E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF GEORGIA   (United States)

^d VisualSonics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; C57BL 6 MOUSE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HIGH FREQUENCY CONTRAST ENHANCED ECHOGRAPHY; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING AND DISPLAY; IN VIVO STUDY; INOCULATION; MELANOMA; MELANOMA CELL; MICROVASCULARIZATION; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RELIABILITY; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION; TUMOR VOLUME; TWO DIMENSIONAL IMAGING; UVEA MELANOMA;

ANIMALS; BLOOD VOLUME; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FEMALE; IMAGING, THREE-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; MELANOMA; MICE; MICE, INBRED C57BL; MICROBUBBLES; NEOVASCULARIZATION, PATHOLOGIC; OBSERVER VARIATION; RANDOM ALLOCATION; UVEAL NEOPLASMS;

EID: 79956007911     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6794     Document Type: Article

References (40)

1. Margo CE, Mulla Z, Billiris K. Incidence of surgically treated uveal melanoma by race and ethnicity. Ophthalmology. 1998;105:1087-1090.
2. Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239-251.
3. Mahoney MC, Burnett WS, Majerovics A, Tanenbaum H. Ophthalmology. 1990;97:1143-1147.
4. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:956-961.
5. McLean IW, Foster WD, Zimmermann LE. Uveal melanoma: localization, size, cell type and enucleation as risk factors in metastasis. Hum Pathol. 1982;13:123-132.
6. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res. 2001;11:255-263.
7. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol. 1977;95:63-69.
8. Karlsson UL, Augsburger JJ, Shields JA, Markoe AM, Brady LW, Woodleigh R. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology. 1989;96:382-388.
9. Martin JA, Robertson DM. Extrascleral extension of choroidal melanoma diagnosed by ultrasound. Ophthalmology. 1983;90:1554-1559.
10. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol. 1997;42:215-232.
11. 125I. Ophthalmology. 1980;87:582-590.
12. Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. Arch Ophthalmol. 2003;121:68-72.
13. Richtig E, Langmann G, Mullner K, et al. Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas. Eye. 2004;18:619-623.
14. Gass JD. Comparison of uveal melanoma growth rates with mitotic index and mortality. Arch Ophthalmol. 1985;103:924-931.
15. Coleman DJ, Silverman RH, Rondeau MJ, Lizzi FL, McLean IW, Jakobiec FA. Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death. Am J Ophthalmol. 1990;110:380-388.
16. Romero JM, Finger PT, Rosen RB, Iezzi R. Three-dimensional ultrasound for the measurement of choroidal melanomas. Arch Ophthalmol. 2001;119:1275-1282.
17. Cusumano A, Coleman DJ, Silverman RH, et al. Three-dimensional ultrasound imaging: clinical applications. Ophthalmology. 1998; 105:300-306.
18. Collaborative Ocular Melanoma Study Group, Boldt HC, Byrne SF, et al. Baseline echographic characteristics of tumors in eyes of patients enrolled in the Collaborative Ocular Melanoma Study: COMS report no. 29. Ophthalmology. 2008;115:1390-1397.
19. Ferrara K, Pollard R, Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng. 2007;9:415-447.
20. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature. 2003;423:153-156.
21. Kaul S. Microbubbles and ultrasound: a bird's eye view. Trans Am Clin Climatol Assoc. 2004;115:137-148.
22. Jakobsen JA. Ultrasound contrast agents: clinical applications. Eur Radiol. 2001;11:1329-1337.
23. Yang X. Nano-and microparticle-based imaging of cardiovascular interventions: overview. Radiology. 2007;243:340-347.
24. Piscaglia F, Lencioni R, Sagrini E, et al. Characterization of focal liver lesions with contrast-enhanced ultrasound. Ultrasound Med Biol. 2010;36:531-550.
25. Grossniklaus HE. Tumor vascularity and hematogenous metastasis in experimental murine intraocular melanoma. Trans Am Ophthalmol Soc. 1998;96:721-752.
26. Foster FS, Zhang MY, Zhou YQ, et al. A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol. 2002;28:1165-1172.
27. Singh AD, Terman S, Sculley L. Estimating choroidal melanoma volume: comparison of methods. Ophthalmology. 2007;114:1212-1214.
28. Chang FM, Hsu KF, Ko HC, et al. Three-dimensional ultrasound assessment of fetal liver volume in normal pregnancy: a comparison of reproducibility with two-dimensional ultrasound and a search for a volume constant. Ultrasound Med Biol. 1997;23:381-389.
29. Gilja OH, Thune N, Matre K, et al. In vitro evaluation of threedimensional ultrasonography in volume estimation of abdominal organs. Ultrasound Med Biol. 1994;20:157-165.
30. Riccabona M, Nelson TR, Pretorius DH, Davidson TE. Distance and volume measurement using three-dimensional ultrasonography. J Ultrasound Med. 1995;14:881-886.
31. Tong S, Downey DB, Cardinal HN, Fenster A. A three-dimensional ultrasound prostate imaging system. Ultrasound Med Biol. 1996; 22:735-746.
32. Libutti SK, Choyke P, Carrasquillo JA, Bacharach S, Neumann RD. Monitoring responses to antiangiogenic agents using non-invasive imaging tests. Cancer J Sci Am. 1999;5:252-256.
33. Nakanouchi T, Okihara K, Kojima M, et al. Possible use of transrectal power Doppler imaging as an indicator of microvascular density of prostate cancer. Urology. 2001;58:573-577.
34. Peters-Engl C, Medl M, Mirau M, et al. Color-coded and spectral Doppler flow in breast carcinomas-relationship with the tumor microvasculature. Breast Cancer Res Treat. 1998;47:83-89.
35. Main ML, Escobar JF, Hall SA, Grayburn PA. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent. J Am Soc Echocardiogr. 1997;10:798-804.
36. Morel DR, Schwieger I, Hohn L, et al. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol. 2000;35:80-85.
37. Moriyasu F, Itoh K. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol. 2009;193:86-95.
38. Hwang M, Hariri G, Lyshchik A, Hallahan DE, Fleischer AC. Correlation of quantified contrast-enhanced sonography with in vivo tumor response. J Ultrasound Med. 2010;29:597-607.
39. Shiyan L, Pintong H, Zongmin W, et al. The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast-enhanced ultrasonography. Ultrasound Med Biol. 2009;35:1086-1091.
40. Toivonen P, Mäkitie T, Kujala E, Kivelä T. Microcirculation and tumor-infiltrating macrophages in choroidal and ciliary body melanoma and corresponding metastases. Invest Ophthalmol Vis Sci. 2004;45:1-6.